دورية أكاديمية

Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus

التفاصيل البيبلوغرافية
العنوان: Glycemic Control after Sleeve Gastrectomy and Roux-En-Y Gastric Bypass in Obese Subjects with Type 2 Diabetes Mellitus
المؤلفون: Wallenius, V, Dirinck, E, Fandriks, L, Maleckas, A, Le Roux, CW, Thorell, A
المساهمون: ONO Pharmaceuticals Co Ltd
المصدر: 1472 ; 1461
بيانات النشر: SPRINGER
سنة النشر: 2017
المجموعة: Imperial College London: Spiral
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Surgery, Obesity, Type 2 diabetes, Gastric bypass, Sleeve gastrectomy, Glycemic, INTENSIVE MEDICAL THERAPY, PROSPECTIVE-RANDOMIZED-TRIAL, IMPROVED GLUCOSE-METABOLISM, BETA-CELL FUNCTION, BARIATRIC SURGERY, TREATMENT ALGORITHM, JOINT STATEMENT, WEIGHT-LOSS, ORGANIZATIONS, IMPROVEMENT, 1103 Clinical Sciences, 1117 Public Health And Health Services
الوصف: Background Roux-en-Y gastric bypass (LRYGB) has weight-independent effects on glycemia in obese type 2 diabetic patients, whereas sleeve gastrectomy (LSG) is less well characterized. This study aims to compare early weight-independent and later weight-dependent glycemic effects of LRYGB and LSG. Methods Eighteen LRYGB and 15 LSG patients were included in the study. Glucose, insulin, GLP-1, and GIP levels were monitored during a modified 30 g oral glucose tolerance test before surgery and 2 days, 3 weeks, and 12 months after surgery. Patients self-monitored glucose levels 2 weeks before and after surgery. Results Postoperative fasting blood glucose decreased similarly in both groups (LRYGB vs. SG; baseline—8.1 ± 0.6 vs. 8.2 ± 0.4 mmol/l, 2 days—7.8 ± 0.5 vs. 7.4 ± 0.3 mmol/l, 3 weeks—6.6 ± 0.4 vs. 6.6 ± 0.3 mmol/l, respectively, P < 0.01 vs. baseline for both groups; 12 months—6.6 ± 0.4 vs. 5.9 ± 0.4, respectively, P < 0.05 for LRYGB and P < 0.001 for LSG vs. baseline, P = ns between the groups at all times). LSG, but not LRYGB, showed increased peak insulin levels 2 days postoperatively (mean ± SEM; LSG + 58 ± 14%, P < 0.01; LRYGB − 8 ± 17%, P = ns). GLP-1 levels increased similarly at 2 days, but were higher in LRYGB at 3 weeks (AUC; 7525 ± 1258 vs. 4779 ± 712 pmol × min, respectively, P < 0.05). GIP levels did not differ. Body mass index (BMI) decreased more after LRYGB than LSG (− 10.1 ± 0.9 vs. − 7.9 ± 0.5 kg/m2, respectively, P < 0.05). Conclusion LRYGB and LSG show very similar effects on glycemic control, despite lower GLP-1 levels and inferior BMI decrease after LSG.
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0960-8923
العلاقة: OBESITY SURGERY; http://hdl.handle.net/10044/1/62761Test; https://dx.doi.org/10.1007/s11695-017-3061-3Test; N/A
DOI: 10.1007/s11695-017-3061-3
الإتاحة: https://doi.org/10.1007/s11695-017-3061-3Test
http://hdl.handle.net/10044/1/62761Test
حقوق: © 2017 The Author(s). Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0Test/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
رقم الانضمام: edsbas.18CBFAC8
قاعدة البيانات: BASE
الوصف
تدمد:09608923
DOI:10.1007/s11695-017-3061-3